Climate Change Data

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Risk of market unpreparedness for new technology
• Risk of insufficient clinical acceptance
• Risk of lack of large-scale implementation
• Competition from international players and new companies
• Changes in trading conditions or other restrictions
• Political risks
• Risk of cyclical factors
• Reprioritization or organizational changes among customers and partners
• Risk of data security breaches
• Monsenso's ability to execute according to the growth plan
• Monsenso's revenue is currently based on relatively few large customer cases
• Monsenso is dependent on attracting and retaining skilled employees
• The quality of Monsenso's solution may prove insufficient for large-scale implementation
• Monsenso is dependent on technical partners and suppliers
• The use of components developed by third parties and open-source technologies
• Monsenso is dependent on IPR (intellectual property rights)
• The company may become involved in legal, arbitration cases, and other disputes
• Monsenso's insurance does not cover all types of losses and liabilities
• Monsenso does not achieve the future budgeted results
• Monsenso may need additional capital
• Monsenso may experience impaired financing opportunities
• Exposure to exchange rate fluctuations
• Placement of net proceeds from the offering
• Shareholders may receive a negative or zero return on investments in the company
• The company's existing major shareholder controls a significant portion of the shares
• The share's liquidity is limited, as there is a limited amount of shares in free trade
• Utilization of the existing warrant program will dilute existing and new shareholders
• Issuance of additional shares in the company may dilute all other shareholders
• The company's ability to pay dividends

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: CE-class I medical device, ISO 27001 – Information security certification, ISO 13485 – Quality assurance certification for medical devices, TGA Class I marking (equivalent to CE for Australia)

Third-party Assurance: PwC

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed